PROGRESSIVE multiple sclerosis (MS) posed an important topic of discussion at the 38th European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress, held in Amsterdam, the Netherlands, between 26th–28th October 2022. Throughout the engaging session on progressive MS, chaired by Kathy Smith, National Multiple Sclerosis Society, New York, USA, and Jan Meilof, University of Groningen, the Netherlands, key learning and focus points to consider for the future of clinical trials and treatments were summarised and spotlighted.

The current treatments for children with multiple sclerosis (MS) was a theme explored in a session at this year’s conference of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), which took place on the 26th–28th October 2022. The speakers shared their insights into the management and clinical consequences of MS in children, and discussed perspectives as to why immunomodulatory treatment is different in children with MS.

With Moderna pledging not to enforce its COVID-19 vaccine patent in 92 LMICs, a hub in South Africa is pushing ahead with replication. Read for more details.

Exploring the mechanisms of action of Tumour Treating Fields (TTFields) therapy, this infographic highlights how TTFields selectively target and disrupt the progression of cancer cells.

The pandemic has exacerbated already troubling trends in the market access but has also created an opportunity for change in how drugs are priced and procured.

New research has indicated that gene variants associated with leukaemia, can produce ‘rogue’ immune cells that drive autoimmune diseases…

Obstructive HCM is a condition in which the heart has thickened walls that are not caused by blockage of the heart valves or by very high blood pressure. For the majority of patients, the cause of their disease has a genetic basis and is hereditary. A genetic test can diagnose HCM in some patients, but the results are inconclusive in others.

The harmful effects of cigarette smoke on human health are well documented and supported by evidence from preclinical, clinical, and epidemiological studies. Cigarette smoking damages multiple organs and leads to 8 million global deaths per year from direct use and passive exposure of cigarette smoke to non-smokers.